Alexandros Tzatsos

A team at the GW Cancer Center will develop a model to study the COMPASS complex in pancreatic cancer and possible targeted therapies

Researchers have found that “squamous-like” pancreatic cancer, a subtype that impacts 15-20 percent of patients, is driven by deregulation of epigenetic mechanisms, resulting in the loss of cell identity and development of highly aggressive and metastatic tumors.